Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

A male with aromatase deficiency improved bone health with estradiol treatment.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Testosterone helps human pancreatic cells increase insulin release.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

The document concludes that understanding sulfation biology is crucial for creating treatments due to its importance in biological functions and disease.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.